Drug class in one race
TYK2/JAK1 drugs for Atopic Dermatitis
2 tracked TYK2/JAK1 drugs in the Atopic Dermatitis race. The class explanation lives on the TYK2/JAK1 page; the full indication pipeline across every mechanism is on the Atopic Dermatitis page.
1 Phase 31 Phase 2
Head-to-head evidence: ICP-332 vs TDM-180935